Aytu BioPharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 150
- Market Cap
- -
- Website
- http://www.aytubio.com
Clinical Trials
5
Active:2
Completed:0
Trial Phases
3 Phases
Phase 1:2
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Not Applicable
1 (25.0%)Phase 3
1 (25.0%)Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.
Phase 3
Suspended
- Conditions
- Vascular Ehlers-Danlos Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Aytu BioPharma, Inc.
- Target Recruit Count
- 260
- Registration Number
- NCT05463679
- Locations
- 🇺🇸
Aytu BioPharma, Englewood, Colorado, United States
Respiratory COVID-19: A Randomized, Sham-Controlled Study
Not Applicable
Withdrawn
- Conditions
- COVID-19 PneumoniaCOVID-19 Respiratory InfectionAcute Respiratory Distress SyndromeCOVID-19 Acute Respiratory Distress Syndrome
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Aytu BioPharma, Inc.
- Registration Number
- NCT05166915
- Locations
- 🇪🇸
Hospital Clinic of Barcelona, Barcelona, Catalan, Spain
🇪🇸Vall d'Hebron University Hospital, Barcelona, Catalan, Spain
A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0
Withdrawn
- Conditions
- Male Infertility
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Aytu BioPharma, Inc.
- Registration Number
- NCT02839447
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸Tulane University, New Orleans, Louisiana, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
News
No news found